Aurobindo drug to enter UK mkt
The drugmaker says the UK entry will make it easier to obtain marketing approvals in other EU countries.india Updated: Aug 09, 2006 17:48 IST
Drugmaker Aurobindo Pharma Ltd said on Wednesday it had an approval from the Medicines and Healthcare products Regulatory Agency to market anti-depressant tablets, mirtazapine, in the United Kingdom.
The approval for 15, 30 and 45-milligram dosages of the drug would make it easier to obtain marketing approvals in other European Union countries, the drug maker said in a statement.
Mirtazapine is the generic version of Organon Inc's Zispin, the company said.
Aurobindo shares were up 1.6 per cent to Rs 623.95 in a firm Mumbai market.